Literature DB >> 26464697

Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.

Dong Liang1, Huanzhou Xue1, Yang Yu1, Feng Lv1, Wei You1, Bin Zhang1.   

Abstract

AIMS: The present study was designed to evaluate the different expression of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) in hepatocellular carcinoma (HCC) tissues and the adjacent normal tissues, further explore the correlation between UHRF1 expression and the prognosis of HCC patients.
METHODS: The UHRF1 expression at protein level in HCC tissues and the adjacent normal tissues were measured by high performance liquid chromatography (HPLC). Chi-square test was used to estimate the relationship between UHRF1 expression and clinicopathologic characteristics of HCC patients. The overall survival of HCC patients with diverse expression of UHRF1 was measured by Kaplan-Meier analysis. Cox regression analysis was conducted to judge the prognostic value of UHRF1 in HCC patients.
RESULTS: The UHRF1 was over-expressed in HCC tissues compared with the adjacent normal tissues according to the outcome of HPLC (P<0.001). Besides, the UHRF1 expression was tightly related to distant metastasis, cancer area, and HBV (P<0.05), but shared no correlation with gender, cirrhosis, and bilirubin (P>0.05). Patients with high UHRF1 expression had a shorter overall survival time than those with low UHRF1 expression (P<0.001). Cox regression analysis showed that UHRF1 was significantly linked with the prognosis of HCC patients (P=0.002, HR=5.807, 95% CI=1.901-17.742).
CONCLUSION: UHRF1 was over-expressed in HCC tissues compared to the adjacent normal tissues and UHRF1 expression shared significant relevance with distant metastasis, cancer area and HBV. It could be an important and independent prognostic biomarker for HCC patients.

Entities:  

Keywords:  HPLC; Hepatocellular carcinoma; UHRF1; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26464697      PMCID: PMC4583929     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Recurrence of hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

2.  The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.

Authors:  Han Zhuo; Junwei Tang; Zhe Lin; Runqiu Jiang; Xudong Zhang; Jie Ji; Ping Wang; Beicheng Sun
Journal:  Mol Carcinog       Date:  2015-01-16       Impact factor: 4.784

3.  Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma.

Authors:  Haiyan Chen; Cuijuan Zhang; Yan Sheng; Shuzhe Yao; Zhiyan Liu; Cheng Zhang; Tingguo Zhang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 4.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  The multi-domain protein Np95 connects DNA methylation and histone modification.

Authors:  Andrea Rottach; Carina Frauer; Garwin Pichler; Ian Marc Bonapace; Fabio Spada; Heinrich Leonhardt
Journal:  Nucleic Acids Res       Date:  2009-12-21       Impact factor: 16.971

6.  Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.

Authors:  Taro Yamashita; Azusa Kitao; Osamu Matsui; Takehiro Hayashi; Kouki Nio; Mitsumasa Kondo; Naoki Ohno; Tosiaki Miyati; Hikari Okada; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Yasuni Nakanuma; Hiroyuki Takamura; Tetsuo Ohta; Yasunari Nakamoto; Masakazu Yamamoto; Tadatoshi Takayama; Shigeki Arii; XinWei Wang; Shuichi Kaneko
Journal:  Hepatology       Date:  2014-09-29       Impact factor: 17.425

7.  Diverse modes of genomic alteration in hepatocellular carcinoma.

Authors:  Suchit Jhunjhunwala; Zhaoshi Jiang; Eric W Stawiski; Florian Gnad; Jinfeng Liu; Oleg Mayba; Pan Du; Jingyu Diao; Stephanie Johnson; Kwong-Fai Wong; Zhibo Gao; Yingrui Li; Thomas D Wu; Sharookh B Kapadia; Zora Modrusan; Dorothy M French; John M Luk; Somasekar Seshagiri; Zemin Zhang
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

8.  Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.

Authors:  Yu Zhang; Zhen Huang; Zhiqiang Zhu; Xin Zheng; Jianwei Liu; Zhiyou Han; Xuetao Ma; Yuhai Zhang
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

9.  Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Authors:  Ke Hao; John M Luk; Nikki P Y Lee; Mao Mao; Chunsheng Zhang; Mark D Ferguson; John Lamb; Hongyue Dai; Irene O Ng; Pak C Sham; Ronnie T P Poon
Journal:  BMC Cancer       Date:  2009-11-03       Impact factor: 4.430

10.  Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors.

Authors:  Giuliana Amaddeo; Cécile Guichard; Sandrine Imbeaud; Jessica Zucman-Rossi
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

View more
  11 in total

1.  UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter.

Authors:  Shui-Ping Gao; He-Fen Sun; Liang-Dong Li; Wen-Yan Fu; Wei Jin
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

2.  Developmental and hormonal regulation of ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 gene expression in ovarian granulosa and theca cells of cattle.

Authors:  Maria Chiara Perego; Breanne C Morrell; Lingna Zhang; Luis F Schütz; Leon J Spicer
Journal:  J Anim Sci       Date:  2020-07-01       Impact factor: 3.159

3.  Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.

Authors:  Zhen-Yu Zhang; Jia-Jun Cai; Jin Hong; Kay Ka-Wai Li; Zhou Ping; Yin Wang; Ho-Keung Ng; Yu Yao; Ying Mao
Journal:  Med Oncol       Date:  2016-07-23       Impact factor: 3.064

4.  Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.

Authors:  Xincheng Liu; Huohui Ou; Leyang Xiang; Xianghong Li; Yu Huang; Dinghua Yang
Journal:  Oncotarget       Date:  2017-02-07

5.  Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.

Authors:  Chuanyuan Wei; Nanhang Lu; Lu Wang; Yong Zhang; Zihao Feng; Yanwen Yang; Fazhi Qi; Jianying Gu
Journal:  Oncol Rep       Date:  2018-04-04       Impact factor: 3.906

6.  UHRF1 is a sensor for DNA interstrand crosslinks.

Authors:  Chih-Chao Liang; Martin A Cohn
Journal:  Oncotarget       Date:  2016-01-05

Review 7.  The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Authors:  Christian Bronner; Marc Mousli; Waseem Ashraf; Abdulkhaleg Ibrahim; Mahmoud Alhosin; Liliyana Zaayter; Khalid Ouararhni; Christophe Papin; Tanveer Ahmad; Ali Hamiche; Yves Mély
Journal:  Oncotarget       Date:  2017-04-24

Review 8.  Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.

Authors:  Debasis Patnaik; Pierre-Olivier Estève; Sriharsa Pradhan
Journal:  Oncotarget       Date:  2018-05-25

9.  Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression.

Authors:  Linsheng Wu; Haoxia Li; Shengyou Chen; Xiaoqiang Wu; Xiaomin Chen; Fangping Wang
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

10.  Overexpression of UHRF1 and its potential role in the development of invasive ductal breast cancer validated by integrative bioinformatics and immunohistochemistry analyses.

Authors:  Yichen Yang; Guanjun Liu; Lifang Qin; Li Ye; Fangheng Zhu; Ying Ying
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.